In vitro fertilization for Orthodox Jewish couples: antagonist cycle modifications allowing for mikveh attendance before oocyte retrieval  David E. Reichman,

Slides:



Advertisements
Similar presentations
Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles  Ryan G. Steward,
Advertisements

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Lynn B. Davis, M. D. , M. S. , Sara J. Champion, M. S. , Steve O
Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient.
A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
Lynn B. Davis, M. D. , M. S. , Sara J. Champion, M. S. , Steve O
Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment  Javier Domingo, M.D., Vicente.
Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing.
Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective,
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Michael M. Alper, M.D.  Fertility and Sterility 
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer 
High serum FSH levels in men with nonobstructive azoospermia does not affect success of microdissection testicular sperm extraction  Ranjith Ramasamy,
Boback M. Berookhim, M. D. , M. B. A. , Gianpiero D. Palermo, M. D
Mohamad Irani, M. D. , David Reichman, M. D. , Alex Robles, M. D
Initial experience with a risk-sharing in vitro fertilization–embryo transfer program with novel features  Jacques P. Stassart, M.D., Romaine B. Bayless,
Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.
Modified natural cycle in in vitro fertilization
Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle  James R. Stelling, M.D., Emily.
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Immunohistochemical expression of endometrial L-selectin ligand is higher in donor egg recipients with embryonic implantation  Mousa I. Shamonki, M.D.,
Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient.
Selection of patients for natural cycle in vitro fertilization combined with in vitro maturation of immature oocytes  Jin-Ho Lim, M.D., Seong-Ho Yang,
Martin D. Keltz, M. D. , Josh C. Skorupski, M. D. , Katrina Bradley, M
Prospective evaluation of luteal phase length and natural fertility
Oocyte cryopreservation
Bradley J. Van Voorhis, M. D. , Rachel B. Mejia, D. O. , William D
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study  Ahmet Erdem, M.D., Mehmet Erdem,
A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization  Laura Detti, M.D., Daniel B. Williams, M.D., Jared.
Development and current applications of assisted fertilization
Ultrashort flare gonadotropin-releasing hormone (GnRH) agonist/GnRH antagonist protocol: a valuable tool in the armamentarium of ovulation induction for.
Effect of Salpingectomy on Ovarian Reserve: A Systematic Review and Meta-Analysis  C.E. Boots, MD, E.A. Seidler, MD, A. Ainsworth, MD, A. Hardi, MLIS,
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose.
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D. 
Nigel Pereira, M. D. , Hency H. Patel, B. S. , Logan D. Stone, B. A
Introduction Fertility and Sterility
From partner's desk to iPad
Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles  Karin.
Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized.
Nigel Pereira, Anna Voskuilen-Gonzalez, Kolbe Hancock, Jovana P
Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer  Shokichi Teramoto,
Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic.
“Information-rich” reproductive outcomes in carriers of a structural chromosome rearrangement ascertained on the basis of recurrent pregnancy loss  Michelle.
In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular.
One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above  Sigal Klipstein, M.D., Meredith.
Live babies born per oocyte retrieved in a subpopulation of oocyte donors with repetitive reproductive success  J. Ryan Martin, M.D., Jason G. Bromer,
David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F
Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D. 
Progesterone level at oocyte retrieval predicts in vitro fertilization success in a short- antagonist protocol: a prospective cohort study  Shweta Nayak,
Regulation of assisted reproductive technologies in the United States
Nulliparity, fertility treatments and twins: a time for rethinking
L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing 
Fertility and Sterility: an evaluation
Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization–embryo transfer  Mohamed.
Relationship between maternal age and aneuploidy in in vitro fertilization pregnancy loss  Steven D Spandorfer, M.D., Owen K Davis, M.D., Larry I Barmat,
Eric S. Surrey, M. D. , Debra A. Minjarez, M. D. , John M. Stevens, B
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists 
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
In vitro sildenafil citrate use as a sperm motility stimulant
Fertility in patients with congenital adrenal hyperplasia
Conversion from assisted reproductive technology to intrauterine insemination in low responders: Is it advantageous?  John M. Norian, M.D., Eric D. Levens,
A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders  Hakan Cakmak, M.D., Nam D. Tran,
Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment  Daniel Bodri, M.D., M.Sc.,
Presentation transcript:

In vitro fertilization for Orthodox Jewish couples: antagonist cycle modifications allowing for mikveh attendance before oocyte retrieval  David E. Reichman, M.D., Anate Aelion Brauer, M.D., Dan Goldschlag, M.D., Glenn Schattman, M.D., Zev Rosenwaks, M.D.  Fertility and Sterility  Volume 99, Issue 5, Pages 1408-1412 (April 2013) DOI: 10.1016/j.fertnstert.2012.11.050 Copyright © 2013 Terms and Conditions

Figure 1 Schematic for in vitro fertilization cycle protocol modification. *Boxes composed of dashed-lines represent optional luteal pretreatment. Fertility and Sterility 2013 99, 1408-1412DOI: (10.1016/j.fertnstert.2012.11.050) Copyright © 2013 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.